Six-month delay for Canada’s new drug pricing rules
Over the last several years, there has been a great deal of uncertainty regarding Canada’s patented drug pricing regime. That uncertainty is set to continue for at least six more months...To view the full article, register now.
Already a subscriber? Click here to view full article